Long-term effects of denosumab: a 10-year single-center retrospective study. [PDF]
Aldegheri F +9 more
europepmc +1 more source
Impact of denosumab therapy on periapical healing following root canal treatment: a 10-year retrospective case-control study. [PDF]
Shin B, Yoon JY, Yoo YJ, Shon WJ.
europepmc +1 more source
Dissociated skeletal response to first-line immunotherapy in synchronous bone metastatic non-small cell lung cancer patients: Clinical profiles and survival benefit of denosumab adjunction. [PDF]
Massy E +14 more
europepmc +1 more source
Revisiting the activate depress free and repeat (ADFR) paradigm: Clinical use of cyclic romosozumab. [PDF]
Hare K +5 more
europepmc +1 more source
RANK/RANKL/OPG Axis Expression and Response to Anti-RANKL Therapy in Gnathic Giant Cell Lesions: A Systematic Review and Meta-Analysis. [PDF]
Mahmood DK, Hama AM, Hashmi AS.
europepmc +1 more source
Denosumab versus zoledronic acid for primary osteoporosis: a 36-month retrospective cohort study on bone mineral density changes. [PDF]
Zou X +5 more
europepmc +1 more source
Mechanisms and management strategies for exacerbated bone loss following denosumab discontinuation. [PDF]
Yang J, Yang M, Zeng Y.
europepmc +1 more source
Primary denosumab therapy for a three-column pediatric cervical aneurysmal bone cyst: illustrative case. [PDF]
Amin M +5 more
europepmc +1 more source
Giant Cell Tumor of the Distal Humerus: A Rare Location With a Good Response to Denosumab. [PDF]
Mohamed El Kerim M +6 more
europepmc +1 more source
Extensive Giant Cell Tumor Involving Entire Tibia with Talar Extension and Pulmonary Metastases: Successful Limb Preservation with Denosumab and Angioembolization. [PDF]
Kumar P, Tandon N, Nishith N, Gulia A.
europepmc +1 more source

